Results 121 to 130 of about 15,844 (160)

Molecular characteristics and prognosis of triple negative breast cancer stratified by HER2 status. [PDF]

Chin Med J (Engl)
Yang X, Wang J, An H, He Y, Gan Y, Chen Q, Liu B, Tang W, Fu G, Jiang Z.   +9 more
europepmc   +1 more source

Endoscopic Ultrasound-Guided Tissue Acquisition for Breast Cancer Liver Metastases Enables the Detection of Biomarkers Essential for Treatment. [PDF]

Cancer Rep (Hoboken)
Takano Y, Tamai N, Yamawaki M, Noda J, Azami T, Niiya F, Maruoka N, Yamagami T, Nagahama M.   +8 more
europepmc   +1 more source

Case report: Spatiotemporal HER2 heterogeneity in AFP-producing gastric cancer: navigating long-term survival with molecularly-guided therapy in a refractory case. [PDF]

Front Immunol
Diao Y, Yin H, Sun X, Dong Q, Zhang J.
europepmc   +1 more source

Copy Number-Based Oncogene Dominance May Suggest ERBB2 Dependence and Trastuzumab Response in HER2-Positive Gastric Cancer. [PDF]

Target Oncol
Wakatsuki T, Yamamoto N, Ishizuka N, Hironaka S, Minashi K, Kadowaki S, Hirano H, Shoji H, Yamaguchi T, Chin K, Ogura M, Nakayama I, Osumi H, Ueki A, Kitano S, Boku N, Yamaguchi K, Takahari D.   +17 more
europepmc   +1 more source

Personalized treatment of HER2-positive lung adenocarcinoma using Human Organoid Drug Sensitivity Test. [PDF]

Hum Vaccin Immunother
Luan T, Fu S, Liu W, Wang S, Xie X, Lin X, Chenli Z, Wang L, Ma K, Ma H, Mo J, Yu B, Yang Q, Xu Y, Jin H, Chen Q, Yao L, Luan Y, Zhong N, Lv Q, Zhang Y, Zhou C.   +21 more
europepmc   +1 more source

Cell-Surface Association between Progelatinases and beta² Integrins : Role of the Complexes in Leukocyte Migration [PDF]

, 2006
Stefanidakis, Michael
core  

Cardiotoxic Effects of Antibody Drug Conjugates vs Standard Chemotherapy in ERBB2-Positive Advanced Breast Cancer: A Systematic Review and Meta-Analysis.

JAMA Netw Open
Seth L, Bhave A, Kollapaneni S, Shah V, Nahle T, Blaes A, Dent S, Hurvitz SA, Guha A.   +8 more
europepmc   +1 more source

Immunohistochemistry for PTEN testing in HR +/HER2- metastatic breast cancer. [PDF]

Virchows Arch
Fusco N, Guerini-Rocco E, Castellano I, Malapelle U.   +3 more
europepmc   +1 more source

Current Clinical Paradigm and Therapeutic Advancements in Thymic Malignancies: A Narrative Review. [PDF]

Cancers (Basel)
Dias E Silva D, Miyamura BV, Mambetsariev I, Fricke J, Arias-Romero J, Kulkarni AA, Khan A, Bruno DS, Malhotra J, Fong A, Kim J, Ladbury C, Amini A, Schvartsman G, Salgia R.   +14 more
europepmc   +1 more source

Editorial expression of concern: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer. [PDF]

Mol Cancer
Corcoran C, Rani S, Breslin S, Gogarty M, Ghobrial IM, Crown J, O'Driscoll L.   +6 more
europepmc   +1 more source